Differences of HBV genotypes and hepatocellular carcinoma in Asian countries

被引:19
|
作者
Orito, Etsuro
Mizokami, Masashi
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Clin Mol Informat Med, Nagoya, Aichi 4678601, Japan
[2] Nagoya City Univ, Grad Sch Med Sci, Dept Gastroenterol & Metab, Nagoya, Aichi 4678601, Japan
关键词
Ba; Bj; epidemiology; HCC; subgenotype; T1653; mutation;
D O I
10.1111/j.1872-034X.2007.00101.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis B virus (HBV) genotype B (HBV B) and genotype C (HBV C) are prevalent in Asia. Recently HBV B has been classified into two subtypes, HBV Ba, which is ubiquitous in Asia, and HBV Bj specific to Japan. However, little is known about etiological, virological and clinical differences among patients who have various genotypes and who developed hepatocellular carcinoma (HCC). We investigated the relation of HBV subgenotype with etiological and clinical differences of HCC patients between Taiwan and Okinawa in Japan. HBV Bj may be associated with lower incidence of HCC and older development of HCC while HBV Ba or HBV C may be associated withhigher incidence of HCC and younger development of HCC. In addition, we demonstrated the relationship of the specific mutation of HBV, T1653 mutation in the core promoter region, with development of HCC in Japanese patients with HBV C. These data suggest that great differences exist among patients with HCC who are infected with different HBV genotypes or genotype-specific mutations.
引用
收藏
页码:S33 / S35
页数:3
相关论文
共 50 条
  • [41] Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues
    Anchalee Tantiwetrueangdet
    Ravat Panvichian
    Pattana Sornmayura
    Natthaporn Sueangoen
    Surasak Leelaudomlipi
    Medical Oncology, 2018, 35
  • [42] INACTIVE HBV REPLICATION AND HBV INTEGRATION IN PRIMARY HEPATOCELLULAR-CARCINOMA IN SARDINIA
    LAI, ME
    FARCI, P
    FIGUS, A
    MULARGIA, AP
    TOCCO, A
    SOLINAS, A
    BALESTRIERI, A
    JOURNAL OF HEPATOLOGY, 1987, 5 : S158 - S158
  • [43] Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissues
    Tantiwetrueangdet, Anchalee
    Panvichian, Ravat
    Sornmayura, Pattana
    Sueangoen, Natthaporn
    Leelaudomlipi, Surasak
    MEDICAL ONCOLOGY, 2018, 35 (10)
  • [44] Ethnic Differences in Clinical Characteristics and Treatments of Asian and Non-Asian With Hepatitis C (HCV)-Related Hepatocellular Carcinoma (HCC)
    Yip, Benjamin
    Ha, Nghiem B.
    Kim, Lily H.
    Ahmed, Aijaz
    Ayoub, Walid
    Cooper, Allen D.
    Daugherty, Tami
    Lutchman, Glen A.
    Garcia, Gabriel
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2012, 142 (05) : S914 - S915
  • [45] Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt
    Ezzat, S
    Abdel-Hamid, M
    Eissa, SAL
    Mokhtar, N
    Labib, NA
    El-Ghorory, L
    Mikhail, NN
    Abdel-Hamid, A
    Hifnawy, T
    Strickland, GT
    Loffredo, CA
    INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2005, 208 (05) : 329 - 339
  • [46] Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma
    Ling-Hao Zhao
    Xiao Liu
    He-Xin Yan
    Wei-Yang Li
    Xi Zeng
    Yuan Yang
    Jie Zhao
    Shi-Ping Liu
    Xue-Han Zhuang
    Chuan Lin
    Chen-Jie Qin
    Yi Zhao
    Ze-Ya Pan
    Gang Huang
    Hui Liu
    Jin Zhang
    Ruo-Yu Wang
    Yun Yang
    Wen Wen
    Gui-Shuai Lv
    Hui-Lu Zhang
    Han Wu
    Shuai Huang
    Ming-Da Wang
    Liang Tang
    Hong-Zhi Cao
    Ling Wang
    Tin-Lap Lee
    Hui Jiang
    Ye-Xiong Tan
    Sheng-Xian Yuan
    Guo-Jun Hou
    Qi-Fei Tao
    Qin-Guo Xu
    Xiu-Qing Zhang
    Meng-Chao Wu
    Xun Xu
    Jun Wang
    Huan-Ming Yang
    Wei-Ping Zhou
    Hong-Yang Wang
    Nature Communications, 7
  • [47] Treatment of HBV infection reduces the risk of hepatocellular carcinoma
    Nature Clinical Practice Gastroenterology & Hepatology, 2009, 6 (1): : 2 - 2
  • [48] Hepatocellular Carcinoma and Antiviral Treatments Against HBV and HCV
    Adhoute, X.
    Sellier, F.
    Fontaine, H.
    Castellani, P.
    Bourliere, M.
    ONCOLOGIE, 2017, 19 (5-6) : 144 - 151
  • [49] CHARACTERISTICS OF HBV INTEGRATION IN PATIENTS WITH AND WITHOUT HEPATOCELLULAR CARCINOMA
    Han, Yan
    Chen, Zhiwei
    Tang, Jing
    Wu, Na
    Ren, Hong
    HEPATOLOGY, 2024, 80
  • [50] HBV AS A PATHOGENIC FACTOR IN THE DEVELOPMENT OF HEPATOCELLULAR-CARCINOMA
    HOFSCHNEIDER, PH
    BAUERLE, P
    CASELMANN, WH
    KEKULE, A
    LAUER, U
    LUBER, B
    MEYER, M
    SCHLUTER, V
    WEISS, L
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1993, 6 (06): : 690 - 690